Regulus Therapeutics Inc. (RGLS) Weighted Average Number of Shares Outstanding, Diluted 2020 - 2023

Historical data

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Regulus Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2020 to 2023.
  • Regulus Therapeutics Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 28.7 M shares, a 70.7% increase year-over-year.
  • Regulus Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 19 M shares, a 24.2% increase from 2022.
  • Regulus Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 15.3 M shares, a 78.1% increase from 2021.
  • Regulus Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 8.57 M shares, a 75.5% decline from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 19 M +3.7 M +24.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 15.3 M +6.69 M +78.1% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 8.57 M -26.4 M -75.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 35 M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.